Leone D. Patterson

Insider Reports History

Location
Washington, DC
Signature
/s/ Daniel Dex, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Leone D. Patterson:

Form 4 holding EVP, Chief Bus & Fin Officer

Zymeworks Inc.

Security class
Restricted Stock Unit
Shares / value
53,000
Estimated value
$790,977
Report date
10 Jan 2025
Price
$14.92
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Fin. and Bus. Officer

Tenaya Therapeutics, Inc.

Security class
Common Stock
Shares / value
95,755
Estimated value
$590,330
Report date
23 Feb 2024
Price
$6.16
Ownership
Direct
Form 4 holding Chief Fin. and Bus. Officer

Tenaya Therapeutics, Inc.

Security class
Stock Option (Right to buy)
Shares / value
205,000
Estimated value
Report date
23 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP, Chief Bus & Fin Officer

Zymeworks Inc.

Security class
Stock Option (Right to Buy)
Shares / value
79,000
Estimated value
Report date
10 Jan 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Nkarta, Inc.

Security class
Stock Option (right to buy)
Shares / value
46,000
Estimated value
Report date
05 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Kalaris Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
18,000
Estimated value
Report date
10 Apr 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Eliem Therapeutics, Inc.

Security class
Stock Option (Right To Buy)
Shares / value
10,000
Estimated value
Report date
19 May 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Leone D. Patterson

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .